Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Medicine|February 10, 2020
Correction to: BAL biomarkers' panel for differential diagnosis of interstitial lung diseasesMiriana d'Alessandro, Alfonso Carleo, Paolo Cameli, et al.
Immunologic Research|May 3, 2023
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathiesEdoardo Conticini, Miriana d'Alessandro, Paolo Cameli, et al.
Biomedicines|June 28, 2023
Immunological Pathways in Sarcoidosis and Autoimmune Rheumatic Disorders-Similarities and Differences in an Italian Prospective Real-Life Preliminary StudyMiriana d'Alessandro, Laura Bergantini, Sara Gangi, et al.
Respiratory Research|June 16, 2023
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorderLaura Bergantini, Margherita Baldassarri, Miriana d'Alessandro, et al.
International Journal of Molecular Sciences|June 28, 2023
Imbalance of Lymphocyte Subsets and CD45RA-Expressing Cells in Intrathoracic Lymph Nodes, Alveolar Compartment and Bloodstream of Pulmonary Sarcoidosis PatientsMiriana d'Alessandro, Laura Bergantini, Sara Gangi, et al.
Journal of Personalized Medicine|January 27, 2026
Uncovering Sex and Gender Differences in Sarcoidosis: A Systematic Review of Current EvidenceTommaso Pianigiani, Beatrice Perea, Akter Dilroba, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2022
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestationsDomenico Plantone, Sara Locci, Laura Bergantini, et al.
Biomedicines|June 28, 2023
MR-proADM as Prognostic Factor of Outcome in COVID-19 PatientsPaolo Cameli, Elena Pordon, Miriana d'Alessandro, et al.
International Immunopharmacology|March 14, 2021
Immunologic responses to antifibrotic treatment in IPF patientsMiriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
International Journal of Environmental Research and Public Health|February 25, 2022
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600IIMiriana d'Alessandro, Laura Bergantini, Dalila Cavallaro, et al.
Pageof 13